1. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS‐HF study. (2nd February 2016) Authors: Chin, Ken Lee; Collier, Timothy J.; Pitt, Bertram; McMurray, John J.V.; Swedberg, Karl; van Veldhuisen, Dirk J.; Pocock, Stuart J.; Vincent, John; Turgonyi, Eva; Zannad, Faiez; Krum, Henry Journal: European journal of heart failure Issue: Volume 18:Number 9(2016) Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗